在心力衰竭患者中癌症的发展和进展
Katharina Seuthe1, Felix Simon Ruben Picard2,3, Holger Winkels2,3
1Department of Cardiology, Clinic III for Internal Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Strasse 62, 50937, Cologne, Germany. katharina.seuthe@uk-koeln.de.
Current heart failure reports
|September 28, 2024
概括
心力衰竭 (HF) 患者的癌症风险和死亡率增加. 新兴研究表明HF可能是癌症的独立风险因素,需要查和有针对性的干预措施.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 翻译医学是一种翻译医学.
背景情况:
- 心力衰竭 (HF) 和癌症的同时发生是一个重大的临床挑战.
- 患有心血管疾病 (CVD) 的患者,特别是HF,患癌症的风险更高.
- 高频和癌症之间的复杂相互作用需要进一步研究.
研究的目的:
- 审查目前对HF患者癌症发展的理解.
- 探索这种关联的潜在机制,风险因素和临床影响.
- 要突出有关HF与癌症之间的联系的新兴研究.
主要方法:
- 对流行病学和临床前数据的文献综述.
- 对现有的心血管试验和分子机制的分析.
- 综合有关HF患者癌症发病率,死亡率和进展的证据.
主要成果:
- 肝炎患者的癌症发病率和死亡率较高,特别是那些具有保留喷射分数的肝炎患者.
- 临床前数据确定了新的途径,例如SerpinA3,可能将HF与癌症进展联系起来.
- 建议HF作为癌症发展的独立风险因素.
结论:
- 初步证据支持HF患者的癌症发展,表明需要临床干预.
- 建议的干预措施包括对HF患者的癌症查以及对这两种疾病的预防策略.
- 需要进一步的研究来阐明HF和癌症之间的分子和细胞交叉对话.
相关概念视频
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure I: Introduction
2
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
2
Heart Failure IV: Classification and Diagnostic Evaluation
2
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
2
Heart Failure V: Nursing Interventions
2
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
2
Heart Failure II: Pathophysiology
3
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
3
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K


